Sign inJoin waitlistJoin the waitlist

Maen Abdelrahim

Medical Director, Cockrell Center for Advanced Therapeutics, Phase I Program · Houston Methodist Hospital

Credentials: · · · · ·

History

Cockrell Center for Advanced Therapeutics · Houston Methodist Hospital
Present

Medical Oncology | Duke University School of Medicine
2015–2017
Internal Medicine
Baylor College of Medicine
2012–2015
Texas A&M University Naresh K. Vashisht College of Medicine
2008–2012

Research

Sp transcription factor family and its role in cancer
Review · European Journal of Cancer · 2005 · 426 citations
Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia
Molecular Psychiatry · 2015 · 333 citations
The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes
Molecular and Cellular Biology · 2003 · 261 citations

Ala Abudayyeh
45 papers · 7 as a resident
Ashish Saharia
28 papers
Mark Ghobrial
28 papers
Sudha Kodali
22 papers
Ashton Connor
18 papers · 6 as a fellow
David Victor
17 papers
Kirk Heyne
16 papers
Osama Gaber
16 papers
Constance Mobley
14 papers
Caroline Simon
12 papers
Yee Cheah
11 papers
Bayan Khasawneh
10 papers · 1 as a resident

Clinical trials

Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
Principal investigator · Recruiting · Phase 2
The Methodist Hospital Research Institute
2026–2029
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
Principal investigator · Recruiting · Phase 2
The Methodist Hospital Research Institute
2025–2029
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
Principal investigator · Enrolling by invitation · Phase 2
The Methodist Hospital Research Institute
2022–2027
NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers
Site PI · Not yet recruiting · Phase 1
The Methodist Hospital Research Institute
2025–2026